Adolescent Opioid Use Disorder: Session 2 of 4

The Health Federation of Philadelphia(HFP) serves as a keystone supporting a network of Community Health Centers as well as the broader base of public and private-sector organizations that deliver health and human services to vulnerable populations.

The Health Federation of Philadelphia

The Poison Control Center’s Opioid Assistance Resource (OAR) webinar series on prescribing, family and pediatric approaches to OUD care

<h3>The Poison Control Center at CHOP’s Opioid Assistance Resource (OAR) Presents:</h3><h2>Adolescent Opioid Use Disorder: Session 2 of 4</h2><h3>The Poison Control Center’s Opioid Assistance Resource (OAR) is organizing a 4-part virtual webinar series focusing on prescribing, family and pediatric approaches to opioid use disorder (OUD) care, and the landscape of substance and opioid treatment in Philadelphia. </h3><h3>This series is part of the OAR collection with support from the Health Federation of Philadelphia&#x27;s <a href="https://surge.healthfederation.org/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Substance Use Response Guidance and Education (SURGE) program</a></h3>About this eventSession #2: Wednesday, September 28, 2022 from 10:00 am - 11:00 am. Online.This session will explore evidence demonstrating how addiction can be considered a pediatric disease as well as treatment currently provided to adolescent patients with Opioid Use Disorder (OUD). Survey data on substance use and overdose death rates among youth will be reviewed. The session will also cover Medications for Opioid Use Disorder (MOUD) for Adolescents, use of telehealth visits, as well as special developmental, ethical, and legal issues.The Poison Control Center at CHOP’s Opioid Assistance Resource: The Poison Control Center at CHOP provides Philadelphia’s medical community with Opioid Assistance Resource support via our 24/7 phone line: 800-222-1222. OAR is here to help you with managing opioid toxicity and initiating buprenorphine for Opioid Use Disorder.Presenter: Dr. Krishna White, MD, MPH <blockquote>Dr. White is an Attending Physician of Adolescent &amp; Addiction Medicine, the Interim Medical Director for Adolescent Medicine Outpatient Clinical Operations, and the Medical Director of Substance Abuse Services for the Craig-Dalsimer Division of Adolescent Medicine at Children’s Hospital of Philadelphia. She is also an Associate Professor of Clinical Pediatrics at the Perelman School of Medicine, University of Pennsylvania.</blockquote>Target Audience: This program is designed for Physicians, Nurse Practitioners (NPs), Physician Assistants (PAs), Clinical Nurse Specialists (CNSs), Certified Registered Nurse Anesthetist (CRNAs), and Certified Nurse-Midwifes (CNMs) able to obtain an X waiver from SAMHSA to prescribe buprenorphine and their care team colleagues.Moderator: Robert Bassett, DO – Associate Medical Director, Poison Control CenterIntroduction: Rachel Linstead Goldsmith, MPA – Comprehensive Opioid Response and Education (CORE) Program CoordinatorLearning Objectives: Upon completion of this live activity, participants will be able to<ol><li>Discuss clinical and social outcomes of the opioid epidemic that impact Adolescent Medicine</li><li>Identify Medications for Opioid Use Disorder available to adolescent patients</li></ol>Accreditation Statement: The Children&#x27;s Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA Credit Designation Statement: The Children&#x27;s Hospital of Philadelphia designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Disclosure Statement: Krishna White, MD, MPH and Robert Bassett, DO (Speakers), Jeanette Trella, PharmD and Lauren Longo, MPH (Course Directors), and Joan Nolan, RN, Rachel Linstead Goldsmith, MPA and Tina Mannices (CME Planners) have no relevant financial relationship with an ineligible company to disclose.Cost: None

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

Adolescent Opioid Use Disorder: Session 2 of 4

More events from The Health Federation of Philadelphia

Discover more events from The Health Federation of Philadelphia, from Health to other experiences you might love.

Adolescent Opioid Use Disorder: Session 2 of 4

More events from The Health Federation of Philadelphia

Discover more events from The Health Federation of Philadelphia, from Health to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.